Amyotrophic lateral sclerosis (ALS) remains a fatal disease with limited therapeutic options.
Signaling via neurotrophins (NTs), neuroinflammation, and certain micro-RNAs are believed …

Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying.
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …

Therapeutic options for amyotrophic lateral sclerosis (ALS) are still limited. Great hopes,
however, are placed in growth factors that show neuroprotective abilities (eg, nerve growth …

In a previous study, we reported that intrathecal injection of mesenchymal stem cells (MSCs)
slowed disease progression in G93A mutant superoxide dismutase1 transgenic mice. In this …

Neural stem or progenitor cells are considered to be a novel therapeutic strategy for
amyotrophic lateral sclerosis (ALS), based on their potential to generate a protective …

Background: Amyotrophic lateral sclerosis (ALS) is an incurable disease. There are vigorous
attempts to develop treatments to reduce the effects of this disease, and among these …

Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no
effective treatment. Stem cell therapy may be one of the promising treatment options for such …

Abstract Introduction Amyotrophic Lateral Sclerosis (ALS) is a devastating
neurodegenerative disorder that progressively leads to motor neuron degeneration at the …

Background Amyotrophic Lateral Sclerosis (ALS) is a multicausal disease characterized by
motor neuron degeneration in the spinal cord and brain. Cell therapy may be a promising …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease
characterized by degeneration of motor neurons in the spinal cord and brain. This disease …